Deadly Cancers Often Get the Least Research Funding.

According to a new study, research is poorly funded for several common and/or deadly cancers, such as endometrial, liver and bile duct, cervical, ovarian, pancreatic, and lung cancer. Study author Dr. Suneel Kamath notes, “The goal of this study is not to divert funds away from cancers that are well-supported, but rather expand funding for other cancers that aren’t getting enough support currently… These are all deadly and life-altering diseases that deserve our attention and support.”

Journal of the National Comprehensive Cancer Network, July 2019